Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader ...

The Post Graduate Certificate Programme in Strategic Management is a capstone business simulation and project-based ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Bucheerei’s appointment comes at a pivotal time as Ithmaar Bank advances its comprehensive restructuring and transformation programme aimed at strengthening its business model ...

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment options.

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Biomind Labs Inc ( ($TSE:BMND) ) has issued an update. Biomind Labs Inc. has announced a significant strategic advancement in the development of ...

An organoid standards working group has been established, bringing together experts from around the world, with Chinese scholars leading the effort to gather international expertise to develop a ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.

Barry Callebaut partners with NotCo AI and Planet A Foods to tackle soaring cocoa prices and regulatory hurdles, leveraging digital formulation tools to future‑proof chocolate ...